Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
USA
International
Media and Investors Resources
Press Release, 8 August 2024
Kuros Biosciences Reports First Half of 2024 Results
Kuros Interim Results, 2024
English version
Press Release, 25 June 2024
Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft
Minutes of the AGM, 17 April 2024
English Version
Minutes of the AGM, 17 April 2024
German Version
Press Release, 24 April 2024
Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales